Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms
Launched by SWANSEA UNIVERSITY · Nov 19, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether omega-3 fatty acids, which are found in fish oil, can help improve sleep, mood, and behavior in children who have sleep problems and symptoms related to Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD). Instead of focusing on specific diagnoses, the study will look at individual symptoms to see which children might benefit the most from taking omega-3 supplements. This approach aims to include a wider range of children, including those who might not have a formal diagnosis but still experience challenges.
Children aged 6 to 12 years old, who can swallow capsules, may be eligible to participate if they show signs of autism or ADHD based on specific questionnaires. The study is currently recruiting participants, and kids with other neurodevelopmental disorders or certain mood and anxiety issues are welcome to join, as long as they don't have major psychiatric conditions that require hospitalization. If your child participates, they will be taking omega-3 supplements and may help researchers learn more about how these supplements can support kids facing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Autism Spectrum Quotient 10 score \>5 OR Conners 3 Handscored Short Parent Form T score \> 64 for either the inattention OR hyperactivity subscales OR Children Sleep Habits Questionnaire SF score \>30 Able to swallow capsules
- Exclusion Criteria:
- • Any major psychiatric condition likely to require hospitalization (e.g., Psychotic Disorders; Eating Disorders), but NB: for representativeness of typical children with ADHD/ASD, diagnosed mood/anxiety/sleep or other neurodevelopmental disorders will not be exclusion criteria; Severe learning difficulties (e.g., Down syndrome) Any serious medical condition; (d) allergy to any ingredients of the intervention or related substances
About Swansea University
Swansea University is a leading research institution located in the United Kingdom, renowned for its commitment to innovative healthcare solutions and advancements in clinical research. With a focus on interdisciplinary collaboration, the university conducts a range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. Leveraging cutting-edge facilities and a team of expert researchers, Swansea University is dedicated to fostering an environment that prioritizes ethical standards, scientific rigor, and the translation of research findings into real-world applications. Through its dedicated clinical trial initiatives, the university plays a pivotal role in advancing evidence-based practices in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Swansea, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported